drugset / Trial / NCT02616354

Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin

NCT02616354

RandomizedParallel-groupSingle-blindTreatment

Summary

Explore Imipenem/Cilastatin two-step dosing compared to 2 hours infusion in patients with severe whether can obtain better results of the pharmacokinetic/pharmacodynamic, for clinical rational use of antimicrobial agents, and provide theoretical support for optimizing dosage regimen.

Timeline

Start
2015-01
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator IMIPENEM ANHYDROUS Small molecule 0.5 g Intravenous
Comparator IMIPENEM ANHYDROUS Small molecule 1 g Intravenous